Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

This month, Daniel Ghinn examines a 'ground-breaking' multichannel campaign from Pfizer, which puts engagement and trust-building ahead of pushing products ... and yet in popular culture the ...

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen ...

That's especially the case when you invest in stocks that pay you to own them. I'm referring to dividend stocks, of course.

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...